Sartorius Unveils Preliminary FY25 Results: Profit Surges on Strong Revenue Momentum

tx_pending_forever · 2026-02-18T18:04:54+00:00

Sartorius Group's preliminary fiscal 2025 results show a net profit surge to 155 million euros, an 84.3% increase. Revenue rose 7.6% to 3.5 billion euros. Management expects continued growth, projecting sales increases of 5%-9% for 2026.

tx_pending_forever

2026-02-18 18:04:54

Abstract generation in progress

Sartorius Group disclosed preliminary fiscal 2025 results that showcase significant financial improvement, with net profit climbing dramatically to 155 million euros, marking an impressive 84.3% jump compared to the prior year. This preliminary data reflects the company’s strengthening market position, though complete audited figures are still pending formal announcement.

Preliminary FY25 Performance Highlights

The preliminary financial snapshot reveals robust underlying performance metrics. Underlying net profit reached 331 million euros, representing an 18.2% increase from 280 million euros in fiscal 2024. Earnings per ordinary share rose to 4.78 euros, up from 4.05 euros the previous year. On the revenue front, sales increased 7.6% in constant currencies to 3.5 billion euros, with reported growth standing at 4.7% for the reporting period. These preliminary numbers underscore Sartorius’s consistent execution of its growth strategy.

Market Response and Share Performance

The preliminary disclosure saw modest market reaction, with Sartorius preferred shares trading at 234.80 euros at the previous close, down 0.4%. Despite the slight pullback, investors appear to be digesting the preliminary results ahead of more detailed disclosures.

Forward Outlook: Preliminary Guidance for FY26

Looking ahead, management maintains a constructive preliminary outlook for fiscal 2026. The company projects sales revenue growth in constant currencies ranging from approximately 5% to 9%, signaling confidence in sustained expansion. The underlying EBITDA margin is anticipated to improve to slightly above 30%, indicating management’s commitment to enhancing operational profitability. These preliminary targets reflect Sartorius’s strategic positioning in the life sciences sector.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes